Capillary Technologies
Capillary Technologies
Information TechnologyKey Fundamentals
MicrocapTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 24.8% CAGR over last 5 years
Weaknesses
5- Stock is trading at 3.58 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -0.78%
- Tax rate seems low
- Company has a low return on equity of -2.31% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 69d agoCapillary Technologies is a mid-cap IT company with a market cap of Rs.4,100 Cr trading at a PE of 78.2x. The company has delivered strong revenue growth of 32% CAGR over 3 years and 109% TTM profit growth, but carries a negative 3-year average ROE of -1% and does not pay dividends.
- Strong revenue growth with compounded sales CAGR of 32% over 3 years and 34% over 5 years, indicating consistent top-line expansion
- Profit growth accelerating sharply with TTM compounded profit growth of 109%, suggesting improving operating leverage
- Company is almost debt-free, significantly reducing financial risk and interest burden
- 5-year compounded profit CAGR of 27% demonstrates sustained earnings momentum beyond just one good year
- Company has actively reduced debt levels, improving balance sheet quality and financial flexibility
- TTM sales growth of 23% indicates continued momentum in the most recent period
- Last year ROE turned positive at 4% after years of negative returns, suggesting a potential inflection point in profitability
- PE ratio of 78.2x is extremely elevated, pricing in significant future growth and leaving little margin of safety
- 3-year average ROE of -1% and 5-year average ROE of -11% indicate historically poor capital efficiency despite recent profits
- Zero dividend yield with no payout despite reporting repeated profits, offering no return to shareholders beyond capital appreciation
- Stock trades at 4.0x book value which is expensive given the historically negative return on equity
- Earnings quality concern as other income of Rs.38.7 Cr forms a material portion of profits, inflating reported earnings
- Tax rate appears low, which may not be sustainable and could compress future net profits when normalized
- Market cap of Rs.4,100 Cr on what appears to be a still-maturing profitability profile creates valuation risk if growth slows
- Despite 5-year profit CAGR of 27%, the base was negative ROE territory, making percentage growth figures optically better than absolute earnings quality
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 69d ago- 7.45 lakh ESOPs granted Jul 1
Capillary Technologies granted 7,45,537 stock options under ESOP Plan 2021 at ₹418 per option for general employees and ₹521.47 for US tax residents.
- Investor conference participation Jun 10
Capillary Technologies will attend the Avendus Spark Small-Cap Investor Conference on June 15, 2026 in Mumbai. No unpublished price sensitive information to be discussed.
TL;DR: Limited news flow for Capillary Technologies with only routine corporate actions reported. The ESOP grant signals employee retention focus but carries mild dilution. No material business updates, order wins, or financial disclosures in the period. Investors should watch for upcoming quarterly results for directional clarity.
Quarterly Results
| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 159 | 152 | 180 | 179 | 184 | 191 | 257 |
| Expenses | 136 | 125 | 162 | 161 | 159 | 160 | 216 |
| Operating Profit | 22.96 | 27.53 | 17.84 | 18.65 | 24.98 | 31.4 | 40.3 |
| OPM % | 14.44% | 18.1% | 9.92% | 10.4% | 13.57% | 16.41% | 15.7% |
| Other Income | 0.34 | -0.66 | 1.16 | 2.18 | 3.68 | 31.67 | -27.68 |
| Interest | 1.67 | 1.6 | 1.17 | 1.77 | 1.46 | 1.07 | 1.17 |
| Depreciation | 12.84 | 16.5 | 17.28 | 19.1 | 19.08 | 19.52 | 20.04 |
| PBT | 8.79 | 8.77 | 0.55 | -0.04 | 8.12 | 42.48 | -8.59 |
| Tax % | -16.72% | -12.2% | -34.55% | -800% | 1.48% | -2.1% | 11.18% |
| Net Profit | 10.26 | 9.84 | 0.75 | 0.29 | 7.99 | 43.36 | -9.55 |
| EPS in Rs | 1.4 | 1.34 | 0.1 | 0.04 | 1.01 | 5.46 | -1.2 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 171 | 223 | 323 | 525 | 598 | 735 | 811 |
| Expenses | 184 | 274 | 387 | 537 | 533 | 642 | 696 |
| Operating Profit | -13 | -51 | -64 | -12 | 65 | 93 | 115 |
| OPM % | -7% | -23% | -20% | -2.2% | 11% | 13% | 14% |
| Other Income | 10 | -15 | 22 | 22 | 13 | 39 | 10 |
| Interest | 2 | 9 | 11 | 18 | 8 | 5 | 5 |
| Depreciation | 18 | 29 | 40 | 56 | 60 | 75 | 78 |
| PBT | -23 | -103 | -93 | -64 | 10 | 51 | 42 |
| Tax % | 1% | -2% | -5% | -11% | -35% | -2% | — |
| Net Profit | -23 | -101 | -88 | -57 | 13 | 52 | 42 |
| EPS in Rs | -97.84 | -20.16 | -16.58 | -7.78 | 1.81 | 6.6 | 5.31 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 10 | 11 | 15 | 15 | 16 |
| Reserves | 10 | 106 | 156 | 524 | 554 | 1,008 |
| Borrowings | 20 | 83 | 149 | 77 | 106 | 54 |
| Other Liabilities | 108 | 149 | 130 | 254 | 163 | 222 |
| Total Liabilities | 140 | 347 | 446 | 870 | 838 | 1,299 |
| Fixed Assets | 27 | 215 | 203 | 298 | 301 | 460 |
| CWIP | 0 | 0 | 6 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 70 | 0 | 136 |
| Other Assets | 113 | 132 | 237 | 499 | 537 | 702 |
| Total Assets | 140 | 347 | 446 | 870 | 838 | 1,299 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 1 | 7 | -20 | 97 | -46 | 150 |
| Investing | -14 | -113 | -100 | -180 | 66 | -590 |
| Financing | 28 | 96 | 137 | 218 | 4 | 270 |
| Net Cash Flow | 15 | -9 | 17 | 134 | 24 | -169 |
| Free Cash Flow | -11 | -10 | -48 | 60 | -94 | 111 |
| CFO/OP | 67 | -20 | 35 | -827 | -65 | 168 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 117 | 93 | 91 | 101 | 98 | 90 |
| Cash Conversion Cycle | 117 | 93 | 91 | 101 | 98 | 90 |
| Working Capital Days | -106 | -184 | -136 | -66 | -28 | -10 |
| ROCE % | — | -68% | -36% | -12% | 2% | 3% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Capillary Technologies insights
57 extracted metrics + investor summaries across FY21–FY27.
Documents
Frequently Asked Questions about Capillary Technologies
What does Capillary Technologies India Ltd do?
Where is Capillary Technologies India Ltd (CAPILLARY) listed?
Which sector does Capillary Technologies India Ltd belong to?
What is the market capitalisation of Capillary Technologies India Ltd?
What is the PE ratio of Capillary Technologies India Ltd?
What is the 52-week high and low of Capillary Technologies India Ltd?
What is the Return on Equity (ROE) of Capillary Technologies India Ltd?
Company Information
Incorporated in 2012, Capillary Technologies India Ltd is a leading Indian software-as-a-service (SaaS) company that specializes in customer loyalty and engagement solutions.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CAPILLARY.md for Capillary Technologies India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.